Thyrocare Technologies Q3 Results | EBITDA surged 32.4%, while the EBITDA margin stood at 25.1% versus 23.4% in the year-ago quarter. Shares of Thyrocare Technologies Ltd ended at ₹787.80, down by ₹10.25, or 1.28%, on the BSE.

Thyrocare Technologies Q3 Results | EBITDA surged 32.4%, while the EBITDA margin stood at 25.1% versus 23.4% in the year-ago quarter. Shares of Thyrocare Technologies Ltd ended at ₹787.80, down by ₹10.25, or 1.28%, on the BSE.
+91 888 718 7394